The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations
不可逆 FGFR 抑制剂 KIN-3248 可克服 FGFR2 激酶结构域突变
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-23-3588
Eranga R Balasooriya #, Qibiao Wu #, Haley Ellis, Yuanli Zhen, Bryanna L Norden, Ryan B Corcoran, Adithi Mohan, Eric Martin, Aleksandra Franovic, John Tyhonas, Matthew Lardy, Kathryn B Grandinetti, Robert Pelham, Liliana Soroceanu, Vanessa S Silveira, Nabeel Bardeesy
